Prediction of the outcome of endovascular treatment in acute ischemic stroke patients
View Patent ↗The present application provides for use of a somatosensory evoked potential (SEP) during the hyperacute stroke phase as marker for predicting the outcome of endovascular treatment in a patient suffering from acute ischemic stroke, wherein when the SEP ipsilateral to the stroke site has an amplitude from 60% to 100% with respect to the corresponding SEP contralateral to the stroke site this is indicative of good outcome of the endovascular treatment, whereas when the SEP ipsilateral to the stroke site has an amplitude from 0% to 20% with respect to the corresponding SEP contralateral to the stroke site this is indicative of bad outcome of the endovascular treatment.
1. A method for treating a patient suffering from acute ischemic stroke, the method comprising:
determining a somatosensory evoked potential (SEP) during a hyperacute stroke phase before endovascular treatment of the patient, wherein an SEP ipsilateral to a stroke site having an amplitude from 60% to 100% with respect to a corresponding SEP contralateral to the stroke site reflects a desired response to endovascular treatment; and
if the determined SEP reflects the desired response to the endovascular treatment, providing the endovascular treatment to the patient, wherein the endovascular treatment comprises intraarterial thrombolysis, mechanical thrombectomy, or a combination thereof.
2. The method according to claim 1 , wherein the SEP is determined by stimulating a median nerve or, alternatively, an ulnar nerve.
3. The method according to claim 2 , wherein the SEP is selected from the N20 and P25 components.
4. The method according to claim 3 , wherein the SEP is N20.
5. The method according to claim 2 , wherein the patient presents with anterior large vessel occlusion.
6. The method according to claim 2 , wherein the patient presents a clinical status as defined by the National Institutes of Health Stroke Scale (NIHSS) equal or above 10.
7. The method according to claim 1 , wherein the SEP is determined by stimulating the tibial nerve.
8. The method according to claim 7 , wherein the SEP is selected from the N35 and P40 components.
9. The method according to claim 8 , wherein the SEP is determined within 8 h from stroke onset or, alternatively, within 120 min from arrival of the patient at a hospital.
10. The method according to claim 9 , wherein the SEP is determined within 6 h from stroke onset or, alternatively, within 90 min from the arrival of the patient at the hospital.
11. The method according to claim 7 , wherein the patient presents with anterior large vessel occlusion.
12. The method according to claim 7 , wherein the patient presents a clinical status as defined by the National Institutes of Health Stroke Scale (NIHSS) equal or above 10.
13. The method according to claim 1 , wherein the patient presents with anterior large vessel occlusion.
14. The method according to claim 1 , wherein the patient presents a clinical status as defined by the National Institutes of Health Stroke Scale (NIHSS) equal or above 10.